T. Rowe Price Associates’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $117K | Hold |
|
|||||
|
2021
Q2 | $189K | Sell |
|
|||||
|
2021
Q1 | $5.71M | Sell |
|
|||||
|
2020
Q4 | $18M | Buy |
|
|||||
|
2020
Q3 | $10.9M | Sell |
|
|||||
|
2020
Q2 | $44.4M | Sell |
|
|||||
|
2020
Q1 | $24M | Buy |
|
|||||
|
2019
Q4 | $14.4M | Buy |
|
|||||
|
2019
Q3 | $5.7M | Buy |
|
|||||
|
2019
Q2 | $6.63M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $21.3M | Sell |
|
|||||
|
2014
Q4 | $53.7M | Sell |
|
|||||
|
2014
Q3 | $34.2M | Buy |
|